APWA
TPST icon

Atlas Private Wealth Advisors’s Tempest Therapeutics TPST Stock Holding History

Atlas Private Wealth Advisors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 642
2021
Q3 		$0 Hold
1
– – ﹤0.01% 816
2021
Q2 		$0 Hold
1
– – ﹤0.01% 940
2021
Q1 		$0 Hold
1
– – ﹤0.01% 912
2020
Q4 		$0 Hold
1
– – ﹤0.01% 790
2020
Q3 		$0 Hold
1
– – ﹤0.01% 730
2020
Q2 		$0 Buy
+1
New +$399 ﹤0.01% 713

Other funds holding TPST

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atlas Private Wealth Advisors's TPST Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Tempest Therapeutics (TPST) in Q4 2021, closing a stake of 1 share.

Atlas Private Wealth Advisors first reported a position in TPST in Q2 2020 and held it in 6 quarters. The position peaked at $0 in Q3 2021. 17 funds tracked by Wall St. Rank hold TPST as of Q4 2021.

  • Atlas Private Wealth Advisors reported no remaining Tempest Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 1 Tempest Therapeutics share in Q4 2021.
  • Atlas Private Wealth Advisors first reported a position in Tempest Therapeutics in Q2 2020 and held it in 6 quarters.
  • Atlas Private Wealth Advisors's Tempest Therapeutics position peaked at $0 in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.